Ann: Corporate Presentation, page-18

I also like you noted the sell down at 9c by Merchant Fund. From the broker report it looked like they wanted to sell 1 miilion shares and they just sat at 9c whilst it got nibbled away. Funny thing was quite recently they said that in their Biotech Fund they were well invested in 3 stocks , being BDX, Innoviq and I forget the other. From memory that was advised on a Livewire, or *, interview... cant remember. So offloading 1 million of BDX soon after was a bit odd, but then again they still hold a lot more as you say, hence I am thinking they just maybe did the sale simply to raise some capital for a splurge into another biotech for the Fund. I do hold both BDX and Innoviq, but my holdings are skewed more significantly to BDX.

By the way, I saw another earlier poster comment that his wife said she would much prefer a blood test to a mammagram. By chance, a few weeks back I had asked my wife what she would prefer and she was quite adamant she would opt for a blood test instead. She finds the annual mammagram quite an ordeal with some (unsolicited) commentary from her on why that is. She said even if its not covered by medical insurance she would still opt for the blood test even if its $350